Axar.az
UP

EU and AstraZeneca reach deal to end vaccine row

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The EU and UK-Swedish drug-maker AstraZeneca have settled a row over a shortfall in coronavirus vaccines that affected the European rollout earlier this year.

Axar.az reports that AstraZeneca has agreed to deliver 200 million doses of its vaccine, which had been promised under a contract, to the EU by the end of March 2022.

The deal puts an end to the EU's pending action in the Belgian courts.

The EU said this week that 70% of adults had been double vaccinated.

Earlier this year AstraZeneca angered European Commission officials when it said it could only deliver a fraction of the doses agreed for the first three months of 2021.

The bitter dispute overshadowed the initial weeks of the vaccine rollout across the EU's 27 countries. The Commission accused the company of breaking an August 2020 advanced purchase deal while AstraZeneca hit back arguing that the contract only required its "best effort" to deliver millions of vaccine doses on time.

Date
2021.09.03 / 23:31
Author
Axar.az
Comments
See also

Pfizer has withdrawn a drug at risk for cancer

China administers over 2 bln COVID-19 vaccine doses

A new strain of the coronavirus is spreading - WHO

Delta variant patients twice as likely need hospital care

5 billion doses of vaccine have been given worldwide

Pfizer COVID-19 vaccine wins full U.S. FDA approval

American expert`s pessimistic statement about COVID-19

Pfizer seen reaping billions from COVID-19 vaccine market

WHO sees possibility of naming new coronavirus strains

Pfizer and Moderna vaccines have risen in price

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla